Saudi Pharmaceutical Industries and Medical Appliances EBIT

The latest EBIT for 2070.SR is $240M as of June 2026. That compares with $220M in the prior-year period — up 8.2% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside Saudi Pharmaceutical Industries and Medical Appliances's historical trend and sector peers before judging valuation or financial health.

Over the past year, 2070.SR's EBIT moved from $220M to $240M — a 8.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Saudi Pharmaceutical Industries and Medical Appliances's operating scale or balance-sheet position.

Against its sector companies, 2070.SR currently prints $240M for EBIT, while the sector average sits near $2.6T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Saudi Pharmaceutical Industries and Medical Appliances's growth, margins, and balance sheet.

A EBIT figure of $240M for 2070.SR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting 2070.SR's EBIT ($240M), review year-over-year change from $220M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.